Canada Pension Plan Investment Board Alnylam Pharmaceuticals, Inc. Transaction History

Canada Pension Plan Investment Board

  • $96.3 Billion
  • Q2 2024

A detailed history of Canada Pension Plan Investment Board transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 283,933 shares of ALNY stock, worth $77.6 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
283,933
Previous 273,790 3.7%
Holding current value
$77.6 Million
Previous $40.9 Million 68.62%
% of portfolio
0.07%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$143.31 - $247.0 $1.45 Million - $2.51 Million
10,143 Added 3.7%
283,933 $69 Million
Q1 2024

May 14, 2024
BUY
$146.51 - $198.2 $4.51 Million - $6.1 Million
30,792 Added 12.67%
273,790 $40.9 Million
Q4 2023

Feb 14, 2024
BUY
$151.41 - $196.57 $13.9 Million - $18 Million
91,700 Added 60.61%
242,998 $46.5 Million
Q3 2023

Nov 09, 2023
SELL
$170.77 - $211.65 $2.77 Million - $3.43 Million
-16,200 Reduced 9.67%
151,298 $26.8 Million
Q2 2023

Aug 09, 2023
SELL
$185.01 - $212.05 $314,517 - $360,485
-1,700 Reduced 1.0%
167,498 $31.8 Million
Q1 2023

May 12, 2023
BUY
$182.66 - $235.53 $19.6 Million - $25.2 Million
107,075 Added 172.36%
169,198 $33.9 Million
Q4 2022

Feb 14, 2023
SELL
$185.53 - $241.31 $1.68 Million - $2.19 Million
-9,060 Reduced 12.73%
62,123 $14.8 Million
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $9.79 Million - $16.4 Million
70,693 Added 14427.14%
71,183 $14.2 Million
Q2 2022

Aug 12, 2022
SELL
$120.42 - $169.29 $62,979 - $88,538
-523 Reduced 51.63%
490 $71,000
Q1 2022

May 13, 2022
SELL
$127.18 - $173.91 $7.01 Million - $9.59 Million
-55,124 Reduced 98.2%
1,013 $165,000
Q4 2021

Feb 14, 2022
SELL
$159.56 - $209.29 $5.61 Million - $7.36 Million
-35,151 Reduced 38.51%
56,137 $9.52 Million
Q3 2021

Nov 15, 2021
BUY
$169.75 - $207.73 $8.76 Million - $10.7 Million
51,598 Added 130.0%
91,288 $17.2 Million
Q2 2021

Aug 16, 2021
SELL
$128.63 - $176.89 $10.1 Million - $13.9 Million
-78,667 Reduced 66.47%
39,690 $6.73 Million
Q1 2021

May 17, 2021
BUY
$126.83 - $175.69 $13.7 Million - $19 Million
108,132 Added 1057.53%
118,357 $16.7 Million
Q4 2020

Feb 17, 2021
SELL
$122.97 - $147.0 $780,613 - $933,156
-6,348 Reduced 38.3%
10,225 $1.33 Million
Q3 2020

Nov 12, 2020
SELL
$121.19 - $165.49 $6.68 Million - $9.12 Million
-55,113 Reduced 76.88%
16,573 $2.41 Million
Q2 2020

Aug 14, 2020
SELL
$104.21 - $156.44 $300,750 - $451,485
-2,886 Reduced 3.87%
71,686 $10.6 Million
Q4 2019

Feb 14, 2020
BUY
$74.51 - $124.23 $3.88 Million - $6.46 Million
52,031 Added 230.83%
74,572 $8.59 Million
Q3 2019

Nov 12, 2019
BUY
$70.9 - $87.82 $1.26 Million - $1.56 Million
17,775 Added 372.95%
22,541 $1.81 Million
Q2 2019

Aug 12, 2019
BUY
$65.86 - $92.79 $168,140 - $236,892
2,553 Added 115.36%
4,766 $346,000
Q1 2019

May 15, 2019
BUY
$72.76 - $93.45 $144,210 - $185,217
1,982 Added 858.01%
2,213 $207,000
Q4 2018

Feb 06, 2019
SELL
$62.67 - $88.33 $943,684 - $1.33 Million
-15,058 Reduced 98.49%
231 $17,000
Q3 2018

Nov 09, 2018
SELL
$87.52 - $122.67 $482,935 - $676,893
-5,518 Reduced 26.52%
15,289 $1.34 Million
Q2 2018

Aug 07, 2018
BUY
$88.31 - $107.8 $1.49 Million - $1.82 Million
16,886 Added 430.66%
20,807 $2.05 Million
Q1 2018

May 14, 2018
SELL
$115.92 - $148.54 $7.78 Million - $9.97 Million
-67,119 Reduced 94.48%
3,921 $467,000
Q4 2017

Feb 14, 2018
SELL
$114.49 - $139.98 $5.38 Million - $6.57 Million
-46,970 Reduced 39.8%
71,040 $9.03 Million
Q3 2017

Oct 30, 2017
SELL
$72.53 - $118.27 $3.47 Million - $5.66 Million
-47,823 Reduced 28.84%
118,010 $13.9 Million
Q2 2017

Jan 31, 2018
BUY
N/A
84,361 Added 103.55%
165,833 $13.2 Million
Q1 2017

Jan 31, 2018
BUY
N/A
81,472
81,472 $4.18 Million

Others Institutions Holding ALNY

# of Institutions
614
Shares Held
108M
Call Options Held
2.33M
Put Options Held
2.17M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $33.6B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email